Iladatuzumab vedotin (DCDS-0780A) is an ADC compound targeting CD79b, conjugated with the cytotoxic drug MMAE through a cleavable dipeptide linker mc-val-cit-PABC, used in the study of non-Hodgkin lymphoma.
Purity:
96.21%
CAS Number:
[1906205-77-3]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted